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Abstract MOM22 of Neurospora crassa was suggested to be 
required for the transfer of mitochondrial precursor proteins from 
the receptors to the protein translocation machinery. We isolated 
a yeast mutant the viability of which depended on the expression 
of the introduced N. crassa MOM22 gene. The mutant cells 
showed defects in protein import into mitochondria when the cells 
were depleted of MOM22. By screening for suppressor genes for 
the mutant, we could identify the yeast gene MA SI 7 encoding the 
functional counterpart of MOM22. The MAS17 gene was found 
to be essential for the viability of yeast cells. 
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I. Introduction 
Most mitochondrial proteins are encoded by the nuclear 
genome, synthesized in the cytosol as a precursor protein, and 
transported to mitochondria. The mitochondrial outer mem- 
brane contains a protein complex mediating the specific recog- 
nition, membrane insertion and translocation of precursor pro- 
teins across the outer membrane. This receptor complex prob- 
ably consists of several different proteins having distinct func- 
tions [1,2]. MAS20 and MAS70 in yeast Saccharomyces serevi- 
siae or MOM 19 and MOM72 in Neurospora crassa apparently 
function as import receptors with overlapping specificities [3 
6]. ISP42 in yeast or MOM38 in N. crassa appears to form a 
machinery that mediates the insertion of precursor proteins 
into the outer membrane and their translocation across the 
membrane [7,8]. MOM22 in N. crassa was suggested to be 
required for the transfer of precursor proteins from the recep- 
tors to the protein translocation machinery involving MOM38 
since the antibodies against MOM22 inhibited the import of 
many mitochondrial precursor proteins into mitochondria but 
not their binding to the receptors in vitro [9]. However, the 
yeast equivalent of MOM22 has not been identified yet and the 
function of MOM22 in vivo remains unknown. 
In order to analyze the roles of MOM22 in mitochondrial 
protein import in vivo, we started identifying the yeast equiva- 
lent of N. crassa MOM22 by the 'cloning-by-function' ap- 
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proach [10]. We obtained a yeast mutant the viability of which 
depended on the expression of the introduced N. crassa 
MOM22 gene. The mutant cells showed defects in protein im- 
port into mitochondria when the cells were depleted of 
N. crassa MOM22. By screening for suppressor genes for the 
mutant strain, we could identify the yeast functional counter- 
part of MOM22, which is now termed MAS17 (for rnitochon- 
drial assembly). Haploid cells lacking a functional copy of 
MAS17 were shown to be inviable, suggesting that MAS17 is 
an essential protein of yeast. 
2. Materials and methods 
2.1. Strains and plasmids 
The following yeast strains were used: CH1305 (MATa ade2 ade3 
leu2 ura3 lys2) [10] and W303 (MATa/MATa ade2-11ade2-1 his3 11, 
151his3-11, 15 ura3 1/ura3-1 leu2-3, 112/leu2~, 112 trpl-1/trpl-1 
can1 lO0/canl-lO0). YeasWEscherichia coli shuttle vector pCHl153 
bearing ADE3 and URA3 as selectable markers, provided by Dr. C. 
Holm (Harvard University), and pYE-Ura3 (Clontech) bearing the 
yeast GAL1-GALIO promoter were used for the expression of the 
N. crassa MOM22 gene in yeast. Plasmid pJJ217 [11] containing the 
HIS3 gene was used for the disruption of MAS17. 
2.2. Isolation of MOM22 cDNA and its expression i  yeast 
The MOM22 cDNA was cloned from the N. crassa cDNA library, 
which was obtained from Fungal Genetics Stock Center (The Univer- 
sity of Kansas Medical Center), by polymerase chain reaction (PCR) 
using primers based on the published sequence [9]. The amplified DNA 
fragment was inserted into pCH1153, placing the gene under control 
of the GALl promoter (derived from pYE-Ura3). The resulting plas- 
mid, pGAL:MOM22, was transformed into yeast strain CH1305. Ex- 
pression of the N. crassa MOM22 gene in yeast was induced by cultivat- 
ing the transformant in rich medium (1% yeast extracts and 2% pol- 
ypeptone) containing 2% galactose, or repressed by cultivating in the 
same medium containing 2% glucose instead of galactose. 
2.3. Isolation of non-sectoring mutants 
CH 1305 cells containing pGAL: MOM22 were mutagenized by UV- 
irradiation, and non-sectoring mutants were isolated according to the 
published procedure [10]. One of the non-sectoring mutants, which 
exhibited galactose-dependent viability and was inviable when grown 
on glucose medium, was designated as MN/M 1-2, and used for further 
experiments. 
2.4. Isolation of the MAS17 gene from yeast 
MN/M1-2 cells were transformed with a yeast genomic DNA library 
which had been constructed on vector YEpM4 (provided by Dr. J. 
Nikawa, Kyusyu Institute of Technology). The transformants were 
screened for the regained ability to grow on glucose medium and to 
produce white sectors, and 16 colonies were isolated. Library plasmid 
DNA was purified from each of the colonies and restriction mapped. 
Comparison of the restriction digests revealed that each plasmid con- 
tained a common 1.7 kb fragment. The DNA fragment was sequenced 
with Taq Dye Primer Cycle Sequencing Kit (Applied Biosystems). 
2.5. Disruption of the MAS17 gene 
The 5'-upstream 770-bp and Y-downstream 450-bp regions flanking 
the MAS17 gene were PCR-amplified and inserted at both sides of the 
0014-5793/95/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(94)01362-4 
M. Nakai, Z Endo/FEBS Letters 357 (1995) 202-206 203 
HIS3 gene of pJJ217. The resulting fragment containing the MAS17 
gene flanking regions and the HIS3 gene was used to transform the 
diploid yeast strain W303. The heterozygous MA $17 diploid strain was 
subjected to tetrad analysis. 
2.6. Production of the anti-MOM22 antiserum 
The N. crassa MOM22 cDNA was ligated into pGEM-EXI expres- 
sion vector (Promega), and the fusion protein between T7 gene 10 
protein and MOM22 was expressed in E. coli cells and purified. The 
fusion protein was used to raise antibodies against MOM22. 
2.7. Miscellaneous 
The following procedures were performed essentially according to 
the published methods: DNA manipulations [12], yeast genetics [13], 
immunoblotting [14], and computer analyses of DNA sequences 
[14,151. 
3. Results and discussion 
We raised antibodies against MOM22 of N. crassa and used 
them to look for a possible yeast homologue of MOM22 by 
immunoblotting. However, the anti-MOM22 antibodies did 
not specifically recognize any yeast mitochondrial protein with 
MW of =20 kDa (data not shown). 
The cloning-by-function strategy is useful for cloning essen- 
tial yeast genes that are functionally equivalent to genes from 
other organisms, even in the case where antibody cross-reaction 
or DNA hybridization does not work [10]. This approach in- 
volves first identifying a yeast mutant hat depends on a plas- 
mid expressing a foreign gene of interest. The corresponding 
yeast gene is then cloned by complementation of the mutant 
defect. The plasmid dependence of the cells can be easily de- 
tected by using a red/white colony sectoring assay [16]. 
In order to apply the cloning-by-function strategy to identify 
a yeast homologue of N. crassa MOM22, we first constructed 
a plasmid-borne N. crassa MOM22 gene the expression of 
which was controlled by the galactose-inducible GAL l  pro- 
moter, and introduced it into the ade2 ade3 yeast strain 
CH 1305. The transformed cells exhibited normal cell growth on 
galactose medium (Fig. 1), and the expression of MOM22 in 
Fig, 1. Galactose-dependent growth of the mutant yeast strain, MN/ 
MI-2. CH1305 cells (1), CH1305 cells harboring pGAL: MOM22 (2) 
and MN/M1-2 cells (3) were streaked onto galactose-containing me-
dium (A) or glucose-containing medium (B), and incubated for 5 days 
at 30°C. 
CH1305 MN/M1-2 
0 16 24 0 16 24 (hr) 
..... I " ' °= 
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Fig. 2. Depletion of N. crassa MOM22 causes impaired mitochondrial 
protein import in MN/M1-2 mutant cells. Strains CH1305 (control) 
and MN/MI-2 (mutant) were grown in rich medium containing 2% 
galactose to late-log phase and then diluted into fresh rich medium 
containing 2% glucose instead of galactose. At various times after 
transfer to glucose medium, cell extracts were prepared and aliquots 
were analyzed for MOM22 (A), Cox IV (B), and F~8 (C) by im- 
munoblotting, mCoxlV, mature form of Cox IV; pFb8 and ruFuS, 
precursor or mature form of F~/L respectively. 
galactose-containing medium was confirmed by immunoblot- 
ting (Fig. 2). Since the introduced plasmid contained the 
ADE3 + gene, the ade2 ADE3 ÷ transformant formed red colo- 
nies with many white ade2 ade3 sectors which resulted from 
frequent plasmid loss events under the non-selectable condi- 
tions [10]. 
The transformed cells were then mutagenized, and the colo- 
nies they produced were examined for sectoring morphology on 
galactose-containing medium. If mutant cells require plasmid 
function for survival, they will form red colonies without white 
sectors. In a screen of 100,000 colonies, several reproducibly 
non-sectoring mutants were isolated. The obtained mutant 
strains were further analyzed as to whether or not they could 
grow on glucose-containing medium, where the expression of 
the introduced N. crassa MOM22 was repressed. One of the 
mutants, named MN/M 1-2, was inviable on glucose-containing 
medium, but viable on galactose-containing medium (Fig. 1), 
suggesting that the growth of the mutant cells depended on the 
expression of N. crassa MOM22.  
If MN/M1-2 carries a mutation in a putative yeast homo- 
logue of the N. crassa MOM22 gene, depletion of N. crassa 
MOM22 in the cells may impair mitochondrial protein import. 
As shown in Fig. 2, by 16 h after transfer to glucose-containing 
medium, N. crassa MOM22 became immunologically non-de- 
tectable in the MN/M1-2 cells. To determine the effect of re- 
duced levels of N. crassa MOM22 on mitochondrial protein 
import in the MN/M 1-2 cells, we analyzed the amounts of the 
mature and/or precursor forms of mitochondrial proteins by 
immunoblotting. The MN/M 1-2 cells started to accumulate he 
precursor form of mitochondrial FI-ATPase fl subunit (F~8) at 
24 h after a shift to glucose-containing medium (Fig. 2), sug- 
gesting a defect in the import of the F~fl precursor into mito- 
chondria. Although accumulation f the precursor of another 
mitochondrial protein, cytochrome oxidase subunit IV (Cox 
IV), was not observed, the amount of mature Cox IV was 
already reduced significantly at 16 h after the shift to glucose- 
containing medium (Fig. 2). This may mean that the import of 
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Fig. 3. Nucleotide sequence of the yeast MAS17 gene (A), comparison of the deduced amino acid sequences of yeast MAS 17 and N. crassa MOM22 
[9] (single letter code) (B), and a hydropathy profile of MAS 17 (C). In the sequence alignment (B), identical amino acid residues are marked by vertical 
bars and basic and acidic residues by + and -,  respectively. Average hydropathicity was calculated by the methods of Kyte and Doolittle [15] with 
a window of 13 amino acids. Putative membrane spanning regions are underlined in B and shaded in C. The sequence data have been submitted 
to the EMBL/GenBank/DDBJ Data Libraries under the accession umber X82405. 
the Cox IV precursor into mitochondria was also impaired but 
that the precursor form was quickly degraded in the cells. These 
results suggest hat the MN/M1-2  mutant has a defect in mito- 
chondrial protein import which could be suppressed by the 
expression of N. crassa MOM22.  The MN/M 1-2 mutant most 
likely carries a mutation in the yeast homologue of the N. crassa 
MOM22 gene. 
Now the yeast gene homologous in function to the N. crassa 
MOM22 gene can be cloned by transforming the MN/M1-2  
mutant with a yeast library and looking for the regained ability 
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Fig. 4. MAS17 is essential for cell viability. Strategy for disruption of 
the MAS17 gene on the yeast chromosome (A) and the results of the 
tetrad analysis of the heterozygous MAS17+lAmas 17 diploid strain on 
glucose-containing medium (B). 
to grow on gluocse medium and to lose the N. crassa MOM22 
gene on the plasmid [10]. The MN/M1 2 strain was thus trans- 
formed with the yeast library, and -40,000 transformants were 
screened irectly on glucose-containing medium for reversal of 
the phenotype. 16 colonies that grew on glucose-containing 
medium were isolated and were found to exhibit the white 
sectoring morphology on both glucose-containing medium and 
galactose-containing medium. The library plasmid was purified 
from each clone, and then restriction mapped. All the plasmids 
contained a common DNA fragment of --- 1.7 kb. The nucleo- 
tide sequence of this fragment revealed an open reading frame 
encoding a putative protein of 152 amino acids with a calcu- 
lated molecular weight of 16,790 (Fig. 3A). As shown in Fig. 
3B, the deduced amino acid sequence shows distinct homology 
to that of N. crassa MOM22 [9] (25% identity). Although the 
sequence homology is somewhat low compared with those for 
MAS20/MOM19 (38% identity), MAS70/MOM72 (29% iden- 
tity) and ISP42/MOM38 (40% identity), the deduced amino 
acid sequence xhibits characteristics ommon to N. crassa 
MOM22, as described below, and we have therefore concluded 
that this open reading frame corresponds to the yeast homo- 
logue of the N. crassa MOM22 gene. This gene was named 
MAS17,  and its gene product MAS17 (a protein of 17 kDa for 
rnitochondrial ssembly). 
Like N. crassa MOM22 [9], MAS17 has a 25-residue un- 
charged hydrophobic stretch (residues 95-119) in the middle of 
the sequence (Fig. 3C), suggesting the same membrane inser- 
tion topology as N. crassa MOM22. Another interesting feature 
shared by MAS17 and MOM22 is that the N-terminal hydro- 
philic regions are highly acidic in both proteins. Since this acidic 
region was found to be exposed to the cytosol in N. crassa 
MOM22 [9] it may provide a binding site for the positively 
charged presequence of mitochondrial precursor proteins. 
The success in identifying the yeast homologue of the 
N. crassa MOM22 gene by the cloning-by-function approach 
in turn suggests that N. crassa MOM22 is functional in yeast 
and that the yeast MOM22 homologue, MAS17, is an essential 
protein of yeast. In order to confirm directly that MAS17 is an 
essential protein of yeast, we disrupted one of the two chromo- 
somal copies of the MAS17 gene with the HIS3  gene in a 
homozygous his3 diploid yeast strain. The diploid cells were 
then sporulated, the resulting tetrads were dissected, and spores 
were allowed to germinate. Only two spores from each tetrad 
formed visible colonies (Fig. 4), and all viable spores were His-, 
indicating that spores carrying the null allele of MAS17 were 
inviable. We concluded that MAS17 is essential for the viability 
of yeast cells. This is in contrast to the other receptor complex 
proteins, MAS20 and MAS70, neither of which is essential for 
protein import or cell viability [3,17,18], but is similar to the 
other proteins (including ISP42, ISP45/MIM44, MAS6/ 
MIM23, Smslp/MIM17, mitochondrial hsp70 and hsp60, 
Ygelp, mitochondrial chaperonin 10, and the two subunits of 
the matrix processing protease) that mediate import, processing 
and folding of nuclear-encoded mitochondrial proteins and are 
essential for cell viability [19-21]. 
We report here the identification of the yeast gene MAS17,  
which encodes a functional equivalent to N. crassa MOM22. 
N. crassa MOM22 was functional in yeast, and the function of 
N. crassa MOM22 or that of yeast MAS17 appears essential 
for mitochondrial protein import and for the viability of yeast 
cells. The availability of the yeast MAS17 gene now paves the 
way for a genetic analysis of the function ofMAS17 (MOM22) 
in mitochondrial protein import. 
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